Gastroesophageal Junction Adenocarcinoma Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
No longer available
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
2022-04-06
Apr 6, 2022
N
Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +27 more
  • Anchorage, Alaska
  • +451 more
2022-04-05
Apr 5, 2022
N
Recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab Deruxtecan (T-DXd)
  • Kashiwa, Chiba, Japan
    National Cancer Center Hospital East
2022-04-05
Apr 5, 2022
N
Recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • non-intervention
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
2022-03-24
Mar 24, 2022
I
Not yet recruiting
  • Gastric Cancer
  • +5 more
  • IMU-131
  • +2 more
  • Woodville South, South Australia, Australia
    The Queen Elizabeth Hospital
2022-03-27
Mar 27, 2022
S
Recruiting
  • Small Cell Lung Cancer
  • +8 more
  • ladiratuzumab vedotin
  • Chandler, Arizona
  • +64 more
2022-04-01
Apr 1, 2022
A
Recruiting
  • Gastric Cancer
  • +2 more
  • Evorpacept (ALX148)
  • +3 more
  • Anaheim, California
  • +18 more
2022-04-01
Apr 1, 2022
A
Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
2022-03-31
Mar 31, 2022
A
Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +31 more
2022-03-23
Mar 23, 2022
N
Active, not recruiting
  • Esophageal Adenocarcinoma
  • +6 more
  • Birmingham, Alabama
  • +633 more
2022-03-19
Mar 19, 2022
E
Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +6 more
2022-03-21
Mar 21, 2022
C
Recruiting
  • Cancer of Head and Neck
  • +10 more
  • OncoPrism™ assay
  • San Francisco, California
    Curebase
2022-03-08
Mar 8, 2022
E
Completed
  • Metastatic Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Akashi, Japan
  • +33 more
2022-02-23
Feb 23, 2022
C
Withdrawn
  • Esophageal Squamous Cell Carcinoma
  • +2 more
  • Duarte, California
  • +2 more
2022-02-21
Feb 21, 2022
M
Completed
  • Gastroesophageal Junction Adenocarcinoma
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-16
Feb 16, 2022
C
Recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • CT041 autologous CAR T-cell injection
  • Physician's Choice(Paclitaxel or Irinotecan or Apatinib or Anti-PD-1 antibody)
  • Hefei, Anhui, China
  • +9 more
2022-02-13
Feb 13, 2022